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Abstract
Low serum concentrations of several vitamins have been linked to increased risk of diseases including insulin resistance and type 2 diabetes
(T2D). Fish is a good source of several vitamins, and the prevalence of T2D is low in populations with high fish intake. The aim of the
present study was to investigate the effects of high fish intake on vitamins in serum from adults in autumn in South-Western Norway at
60° north latitude. In this randomised clinical trial, sixty-three healthy participants with overweight/obesity consumed 750 g/week of either
cod (n 22) or salmon (n 22) as five weekly dinners or were instructed to continue their normal eating habits but avoid fish intake (Control group,
n 19) for 8 weeks. The estimated vitamin D intake was significantly increased in the Salmon group when compared with the Cod group
(P= 6·3 × 10−4) and with the Control group (P= 3·5 × 10−6), with no differences between groups for estimated intake of vitamins A, B1, B2,
B3, B6, B9, C and E. Serum 25-hydroxyvitamin D3 concentration was decreased in all groups after 8 weeks; however, the reduction in the
Salmon group was significantly smaller compared with the Cod group (P= 0·013) and the Control group (P= 0·0060). Cod and salmon intake
did not affect serum concentrations of the other measured vitamins. The findings suggest that 750 g/week of salmonwas not sufficient to prevent
a decrease in serum 25-hydroxyvitamin D3 in autumn in South-Western Norway in adults with overweight/obesity.
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Fish is a good dietary source of nutrients such as proteins, fats,
and several vitamins and minerals; however, the contents of
nutrients in fish varies across fish species(1). Fish consumption
is associated with reduced risk of diseases such as type 2
diabetes and CVD(2–8), and the health benefits of fish consump-
tion have traditionally been attributed mainly to the effects of
n-3 PUFA and vitamin D, especially from fatty fish. Vitamins
play essential roles in numerous processes in the body,
including metabolism of carbohydrates, fatty acids and amino
acids(9–15). Low serum concentrations of fat-soluble and water-
soluble vitamins have been linked to the risk of developing
obesity-related co-morbidities including insulin resistance
and type 2 diabetes, and low circulating concentration of
25-hydroxyvitamin D3 is associated with increased risk of
cardiovascular events(16,17). In Norway, vitamin fortification is
limited to dairy products (vitamin D) and margarine (vitamins
A and D)(18). Cutaneous synthesis of 25-hydroxyvitamin D3
stimulated by sunlight is the major source of vitamin D in
humans(19); therefore, vitaminD-rich foods such as fatty fish, sea-
food, cod-liver oil, entrails and fortified products are important
food sources in northern countries such as Norway in late
autumn, winter and early spring when exposure to UVB radia-
tion is low.
We have previously demonstrated that a high salmon intake
(750 g/week) for 8 weeks improved post-prandial glucose regu-
lation in study participants with overweight/obesity, whereas
high cod intake (750 g/week) did not affect glucose regulation
in the same study setting(20). In the present study, we wanted
to further explore the biological materials from this randomised
clinical trial to gain insight into if a high intake of cod or salmon
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would affect serum vitamin status. The aim of the present study
was to investigate effects of high intake of salmon or cod on
serum vitamin status. The intervention was conducted in the
autumn of 2011 in South-Western Norway (60° north latitude).
Our hypothesis was that the high salmon intake would prevent
the normal seasonal decline in circulating vitamin D concentra-
tion in autumn and that high intake of cod or salmon would
improve the general vitamin status.
Methods
Participants, study setting and ethics
The study design, the description of study participants, the
study setting and the protocol for study visits have been pub-
lished in detail previously(20). In brief, the study population
consisted of adults with overweight or obesity and all partici-
pants were of Norwegian ethnic origin (Caucasian) living in
the Bergen area in South-Western Norway at 60° north latitude.
Inclusion criteria were: BMI ≥ 27 kg/m2, fasting blood glu-
cose ≤ 7·0 mmol/l and age 18–69 years. Exclusion criteria were
high habitual fish/seafood intake (>500 g/week), pregnancy,
incompatibility with fish consumption (allergies, intolerance
and/or dislike), diagnosed diabetes mellitus, heart disease or
gastrointestinal diseases, use of medications affecting lipid
metabolism or glucose homoeostasis, use of anti-inflammatory
medications, use of supplements containing n-3 PUFA, inten-
tional weight loss and large fluctuation in body weight (>3 kg)
over the previous 2 months. Participants were interviewed
about their fish/seafood intake before they were included in
the study, and those with a regular fish intake >1 fish dinner
per week were instructed to avoid eating fish for 4 weeks
before the baseline visit.
The study was designed as a randomised, controlled inter-
vention study with a parallel group design, with three interven-
tion arms: Atlantic cod (wild-caught Gadus morhua) in weekly
doses of 750 g, salmon (farmed Salmo salar) in weekly doses of
750 g and a no-fish group as the Control group. The intervention
period was 8 weeks. In all, seventy-six participants were
included in the study and were randomly assigned to the Cod
group (n 27), Salmon group (n 27) or the Control group
(n 22). The participants were randomised into the different
groups by the project manager by drawing lots, and the partic-
ipants were informed about their group allocation during the
baseline visit. All examinations were conducted at the Clinical
Research Unit at the Haukeland University Hospital, Bergen,
Norway. To enhance compliance, the participants were con-
tacted by phone approximately 1 week prior to baseline and
endpoint visits, during which they were informed of the
schedule and procedures for the following visit. Also, a text
message was sent 1–3 d before the 8-week visit, as a reminder
of how to prepare for the upcoming visit. For any inquires
during the trial period, members of the research group could
be reached by email or telephone. Compliance was monitored
through interviews; after 1, 4 and 8 weeks intervention, the
participants in the fish-eating groups were asked how many
dinners with cod/salmon they had not eaten since last contact,
instead of asking howwell they had complied, to lower the bar
for reporting missing intake. Non-compliance was defined as
not following the protocol in regard to fish intake (omitting
more than three fish dinners in the fish-eating groups), other
dietary changes or use of prescriptionmedicine not compatible
with the inclusion criteria, or changes in physical activity. As
reward for completing the study, participants were offered a
dietary consultation with a student dietitian at the last visit
and all the results of analyses of blood samples.
The study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures
were approved by the Regional Committee for Medical and
Health Research Ethics of Western Norway (REC no.: 2011/572).
Written informed consent was obtained from all subjects.
Health professionals performing blood sampling, and
personnel conducting the laboratory analyses, were all
blinded to participants’ identity and group allocation. All data
were analysed anonymously. This trial was registered at
clinicaltrials.gov as NCT02350595.
Interventions
Cod and salmon fillets were provided to the participants
as frozen-skin and boneless-fillet portions (mean weight
150 (SD 10) g; Lerøy Seafood Group ASA), and pallets of fish
were chosen at random from Lerøy’s warehouse in Bergen,
Norway. The cod and salmon fillets were supplied free of
charge to the participants and were distributed at the baseline
visit or at any time during the study period, if preferred.
Participants in the Cod group were instructed to eat five din-
ners per week containing 150 g of cod fillet, and participants
in the Salmon group were instructed to eat five dinners per week
containing 150 g of salmon fillet. The participants in the fish-eating
groups were told not to exceed a total amount of 750 g of fish/
week, not to consume any other types of fish or seafood during
the study period and to maintain their normal eating habits
throughout the study period apart from eating the mandatory
amount of 750 g fish/week. The Control group was instructed
to continue their normal eating habits, except to avoid fish and
seafood intake. Subjects in all groups were instructed not to
change their physical activity level during the intervention
period. The participants’ dietary intake and habitual lifestyle were
recorded at baseline and endpoint visits, using food record charts
and a questionnaire for reporting physical activity. Reported
energy and macronutrient intake and physical activity were not
changed within the groups during the study period(20).
Protocol for study visits
The total study period was 8 weeks, with baseline visits between
22 August 2011 and 19 September 2011. Examinations were
conducted in the morning after an overnight fast. The subjects
were instructed not to eat or drink anything except water, and
not to use substances containing nicotine after 22 h the previous
day, and to avoid physical exercise and alcohol for 24 h before
each sampling day.
Body height was measured at the baseline visit, using a wall-
mounted stadiometer (Seca 222; Seca). Body weight and body
compositionweremeasured in a fasted state using a bioelectrical
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impedance analysis device (InBody 720; Biospace Co. Ltd) at the
baseline and endpoint visits.
Fasting blood samples were collected at baseline and
endpoint, in BD Vacutainer SST II Advance gel tubes (Becton,
Dickinson and Company) for isolation of serum. The staff com-
plied with a strict protocol for pre-analytical sample handling to
ensure high sample quality. Blood samples were centrifuged
after 30 min at room temperature, and serum were immediately
aliquoted and frozen at −80°C until analyses.
Estimation of vitamin intakes from dietary records
Participants completed dietary records of the 5 preceding days
before the baseline visit and the 5 preceding days before the
8-week visit, including at least 1 weekend day. The estimated
intakes of vitamins A, B1, B2, B3, B6, B9, C, D and E were cal-
culated from the participants’ dietary records using the ‘Mat på
Data 5.1’ software(21), which contains information on the nutrient
contents in food items sold in Norway. This food database does
not contain information of vitamins B12 and K1 contents in foods.
Food records were checked for completeness at both study
visits.
Analyses of serum samples
Vitamin B1 (thiamine and thiamine monophosphate), vitamin B2
(riboflavin and flavinmononucleotide), vitamin B3 (nicotinic acid,
nicotinamide andN1-methylnicotinamide), vitamin B6 (pyridoxal
5 0-phosphate, pyridoxal, pyridoxine and 4-pyridoxic acid) were
analysed in serum by Bevital AS (http://www.bevital.no)
using liquid chromatography combined with tandem MS, as
previously described(22). Thiamine, thiamine monophosphate,
nicotinic acid, nicotinamide and N1-methylnicotinamide with
corresponding isotope labelled internal standards were added
to the previously published assay(22). Vitamin A (all-trans retinol),
vitamin D (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3),
vitamin E (α-tocopherol and γ-tocopherol) and vitamin K1 (phyl-
loquinone) were measured by liquid chromatography–tandem
MS(23), and vitamin B12(24) and folate(25) by microbiological
assays. Serum concentration of vitamin K1 was below the level
of detection (0·33 nmol/l) for sixteen samples, for these we used
the value level of detection divided by 2. Serum concentrations
of 25-hydroxyvitamin D2, nicotinic acid and pyridoxine were
below level of detection in all samples.
Outcome measurements
The primary outcome of the present study was changes in serum
vitamin D concentration after a weekly intake of 750 g fillet from
either salmon or cod for 8 weeks. Secondary outcomes were
changes in serum concentrations of other fat-soluble and
water-soluble vitamins and changes in estimated dietary intakes
of vitamins within the groups over time.
Sample size estimation
The sample size calculation for this trial was originally con-
ducted with the aim to investigate the effects of high intake
of cod or salmon on post-prandial glucose regulation after a
standardised breakfast in participants with overweight or
obesity(20). We estimated that it was necessary to include
seventy-six participants divided into three groups to ensure
that twenty participants in each group completed the trial with
satisfactory compliance, with a power of 80 % and α of 0·05,
and of these sixty-five participants were included in statistical
analyses(20). In the present study, we wanted to further
explore the biological materials from this randomised clinical
trial to investigate if a high intake of cod or salmon would
affect serum vitamin status. The primary aim of the present
study was to investigate the effects of high intake of salmon
or cod on changes in serum vitamin D concentration in
autumn at 60° north latitude. From two of the participants,
we did not have a sufficient amount of blood serum left
for analyses; thus, we had serum samples from sixty-three
subjects available for laboratory and statistical analyses.
This is the first study to investigate the effects of 8 weeks
of high intake (750 g/week) of cod or salmon on serum vitamin
status in adults with overweight/obesity living in South-Western
Norway; therefore, no data are available for sample size calcu-
lation for the present study. However, sample size estimation
using data from a pilot study conducted in spring in Bergen,
Norway, with normal-weight adults consuming 750 g/week
of cod, salmon or chicken for 4 weeks showed that thirteen par-
ticipants in each group were sufficient to detect differences
between groups for changes in vitamin D, with a power of
80 % and α of 0·05. Based on this, the present study where
19–22 adults with overweight/obesity consume 750 g/week
of cod, salmon or fish-free diet for 8 weeks should have the suf-
ficient statistical strength for comparing changes in vitamin D
in autumn at 60° north latitude between groups consuming
cod, salmon or fish-free diet.
Statistical analyses
Statistical analyses were conducted using SPSS Statistics 25
(SPSS, Inc., IBM Company). Subjects who did not complete
the study were excluded from the statistical analyses. For analy-
tes in serum and for estimated intake of vitamins from dietary
records, most data were not normally distributed according
to the Shapiro–Wilk test and non-parametric tests were used
to investigate changes within groups (Wilcoxon signed-rank
test). For these non-parametric data, the Kruskal–Wallis test
was used to compare values between the three groups at
baseline. Changes within the groups were compared using
univariate ANCOVA with adjustment for baseline values after
log transformation, followed by the Tukey’s honestly significant
difference test whenever between-group differences were
detected. Data are expressed as medians and 25th, 75th
percentiles. Categorical data were compared using Pearson’s




In total, seventy-six participants were included in the study
and completed the first study visit, and sixty-eight participants









niversity of Bergen , on 11 D
ec 2020 at 09:17:53 , subject to the Cam
bridge Core term






completed the trial. One participant (a woman in the Salmon
group) was excluded from statistical analysis after analyses of
post-prandial blood glucose that revealed she had prediabetes,
and two participants (onewoman in the Cod group and oneman
in the Salmon group) were withdrawn from analysis because
they did not comply with the protocol. From two of the partic-
ipants (one man in the Salmon group and one man in the
Control group), we did not have a sufficient amount of blood
serum for analyses; therefore, these two subjects are excluded
from all analyses in the present paper. In total, sixty-three sub-
jects (twenty-seven men and thirty-six women) were included
in the statistical analyses. The flow of participants in the study
is presented in Fig. 1.
Groups were similar at baseline in regard to sex distribu-
tion, age, BMI, percentage body fat and percentage muscle
mass (Table 1), with median age 45·6 (25th, 75th percentiles
37·1, 53·9) years and median BMI 32·3 (25th, 75th percentiles
29·6, 35·7) kg/m2. After 8 weeks, no changes were seen in any
of the groups for BMI, percentage body fat or muscle mass
(data not presented).
Estimated dietary intake of vitamins
The participants registered food intake for the last 5 d before
the endpoint visit. The Cod group reported that 71 % of dinners
contained cod, whereas 16 % of the meat for dinners was
sausages, minced meat, hamburger or pizza/lasagne with meat,
4 % of dinners contained chicken, 4 % contained lamb, with only
one reported meat-free dinner. In the Salmon group, 71% of
dinners contained salmon, whereas 15% of dinners contained
meat from sausages, minced meat, hamburger or pizza/lasagne,
6 % of dinners contained pork, 4 % contained chicken, and no
meat-free dinnerswere reported. Participants in theControl group,
who were not allowed to eat fish or seafood during the
intervention period, preferred to include meat as part of their
dinners; of the ninety-five dinners registered by the nineteen
participants in the Control group, only one of the reported
dinners did not contain meat. The most popular types of meat
for dinner in the Control group were sausages, minced meat,
hamburger and pizza/lasagne with meat (a total of 48 % of
the dinners), followed by pork (17 % of dinners) and chicken
(12 % of dinners). None of the participants in any of the three
groups reported intake of liver or kidney in their food diaries
before the baseline and endpoint visits.
The estimated median intakes of vitamins A, B1, B2, B3, B6,
B9, C, D and E were similar between the groups at baseline
(Kruskal–Wallis test, P> 0·05). The estimated vitamin D intake
was significantly increased from baseline to 8 weeks in the
Salmon group when compared with both the Cod group and
the Control group (Table 2). For the other vitamins, no changes
were seen in estimated daily intake within any of the groups
from baseline to 8 weeks.
Vitamins in serum
Concentrations of all-trans retinol, thiamine, thiamine mono-
phosphate, riboflavin, flavin mononucleotide, nicotinamide, N1-
methylnicotinamide, pyridoxal 5 0-phosphate, pyridoxal, 4-pyri-
doxic acid, folate, cobalamin, 25-hydroxyvitamin D3, α-
tocopherol, γ-tocopherol and phylloquinone in serum were
similar between the groups at baseline (Kruskal–Wallis test,
P > 0·05) (Table 3).
Serum 25-hydroxyvitamin D3 concentration was significantly
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Fig. 1. Flow diagram displaying the progress of participants during the study period. Participants who did not comply with the study protocol were excluded from
statistical analysis. Non-compliance was defined as not following the protocol in regard to fish intake (omitting more than three fish dinners in the fish-eating groups),
other dietary changes or use of prescription medicine not compatible with the inclusion criteria, or changes in physical activity.
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the reduction in vitamin D3 in the Salmon group was signifi-
cantly smaller when compared with both the Cod group
and the Control group (Fig. 2). Otherwise, no changes were
seen in serum concentrations for the other vitamins during
the intervention period (Table 3).
Discussion
In the present studywe investigated the effects of high intake of
cod or salmon fillets on serum concentrations of a comprehen-
sive panel of water-soluble and fat-soluble vitamins. We
observed that a weekly intake of 750 g salmon fillet curbed
Table 1. Participant characteristics at baseline
(Medians and 25th, 75th percentiles)








Men/women 10/12 8/14 9/10 0·74
Age (years) 47·2 38·0, 54·2 46·1 43·2, 52·6 40·1 31·0, 54·4 0·44
BMI (kg/m2) 31·0 29·2, 35·9 32·2 29·9, 34·7 33·9 29·1, 36·6 0·73
Body fat (%) 39·3 28·3, 42·9 40·2 30·1, 43·0 39·3 33·1, 41·2 0·92
Muscle mass (%) 34·4 32·5, 41·4 33·3 31·5, 40·0 33·9 32·2, 38·2 0·72
* Groups were compared at baseline using Pearson’s χ2 (categorical data) or the Kruskal–Wallis test (continuous data).
Table 2. Estimated daily dietary intake of vitamins based on 5 d dietary records at baseline and after 8 weeks*
(Medians and 25th, 75th percentiles)
Baseline 8 weeks
P† P‡ P§Median 25th, 75th percentiles Median 25th, 75th percentiles
Vitamin A (retinol activity equivalents/d)
Cod group 591 425, 934 661 428, 809 0·41 0·40
Salmon group 634 517, 941 618 553, 734 0·30
Control group 559 399, 825 515 418, 708 0·95
Vitamin B1 (mg/d)
Cod group 1·27 1·05, 1·52 1·29 0·97, 1·48 0·49 0·65
Salmon group 1·36 1·09, 1·68 1·32 1·04, 1·46 0·72
Control group 1·34 1·17, 1·58 1·27 1·10, 1·72 0·85
Vitamin B2 (mg/d)
Cod group 1·58 1·25, 2·03 1·53 1·21, 1·83 0·46 0·79
Salmon group 1·50 1·33, 1·85 1·37 1·27, 1·69 0·21
Control group 1·43 1·27, 1·89 1·52 1·20, 1·80 0·83
Niacin (niacin equivalents/d)
Cod group 37·8 28·2, 44·8 34·3 23·5, 40·8 0·15 0·56
Salmon group 32·0 27·4, 43·0 35·9 33·7, 40·7 0·43
Control group 34·3 29·5, 39·3 33·3 28·7, 47·3 0·42
Vitamin B6 (mg/d)
Cod group 1·53 1·24, 1·83 1·46 1·16, 1·62 0·10 0·59
Salmon group 1·40 1·29, 1·82 1·58 1·38, 1·92 0·50
Control group 1·42 1·23, 1·75 1·61 1·22, 1·84 0·66
Folate (μg/d)
Cod group 200 177, 243 205 165, 251 0·96 0·26
Salmon group 214 172, 244 194 158, 218 0·18
Control group 187 163, 222 188 170, 233 0·50
Vitamin C (mg/d)
Cod group 88·5 51·5, 112·5 74·0 48·3, 120·8 0·58 0·26
Salmon group 71·0 46·0, 92·8 59·0 36·0, 95·5 0·77
Control group 64·0 38·0, 84·0 72·0 47·8, 125·3 0·12
Vitamin D (μg/d)
Cod group 3·8 2·1, 7·6 4·6 3·5, 5·2 0·72 1·1 × 10−13 0·22A
Salmon group 4·7 2·9, 6·7 11·9 10·0, 14·0 2·1 × 10−4 3·5 × 10−6B
Control group 3·9 1·6, 6·5 2·1 1·4, 3·2 0·011 6·3 × 10−4C
Vitamin E (α-tocopherol equivalents/d)
Cod group 11·5 7·5, 14·0 10·6 9·4, 11·7 0·52 0·67
Salmon group 11·5 6·9, 14·3 11·1 8·6, 12·7 0·69
Control group 10·0 7·2, 12·7 10·6 8·4, 14·5 0·34
* No differences were seen between the groups at baseline (Kruskal–Wallis test). Results are presented for twenty-two participants in the Cod group, twenty-two participants in the
Salmon group and nineteen participants in the Control group.
†Within-group changes were tested using Wilcoxon’s signed-rank test.
‡ Changes within the Cod group, Salmon group and Control group were compared using ANCOVA with adjustment for baseline values after log transformation.
§ Changeswithin theCod groupwere comparedwith theControl group (A), changeswithin the Salmon groupwere comparedwith theControl group (B), changeswithin theCod group
were compared with the Salmon group (C) using Tukey’s honestly significant difference test when the ANCOVA test showed differences between the groups.
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Table 3. Serum concentrations of vitamins at baseline and after 8 weeks*
(Medians and 25th, 75th percentiles)
Baseline 8 weeks
P† P‡ P§Median 25th, 75th percentiles Median 25th, 75th percentiles
All-trans retinol (vitamin A) (μmol/l)
Cod group 2·26 1·92, 2·64 2·30 1·86, 2·59 0·53 0·97
Salmon group 2·22 1·81, 2·59 2·11 1·79, 2·62 0·96
Control group 2·06 1·66, 2·41 2·05 1·63, 2·44 0·76
Thiamine (vitamin B1) (nmol/l)
Cod group 6·5 5·7, 7·9 6·3 5·6, 7·0 0·18 0·19
Salmon group 7·2 5·9, 8·6 7·1 6·1, 8·1 0·91
Control group 7·1 6·6, 8·2 7·3 6·2, 9·1 0·92
Thiamine monophosphate (vitamin B1) (nmol/l)
Cod group 3·1 2·4, 3·9 3·1 1·9, 4·3 0·53 0·85
Salmon group 3·6 2·7, 5·0 3·8 3·2, 4·7 0·83
Control group 2·6 2·3, 3·8 3·6 2·5, 4·0 0·63
Riboflavin (vitamin B2) (nmol/l)
Cod group 16·2 10·1, 24·0 17·6 8·0, 21·9 0·45 0·88
Salmon group 13·8 11·0, 17·0 13·5 11·0, 18·5 0·31
Control group 15·8 13·2, 23·0 16·1 9·3, 27·2 0·78
Flavin mononucleotide (vitamin B2) (nmol/l)
Cod group 7·9 6·2, 10·2 8·0 6·7, 10·2 0·81 0·079
Salmon group 9·3 6·3, 13·5 8·4 5·3, 11·6 0·012
Control group 8·7 6·5, 10·8 7·7 6·0, 9·2 0·12
Nicotinamide (vitamin B3) (nmol/l)
Cod group 228 187, 309 218 186, 283 0·11 0·72
Salmon group 200 120, 291 207 168, 256 0·77
Control group 226 170, 354 230 163, 305 074
N1-methylnicotinamide (vitamin B3) (nmol/l)
Cod group 133 112, 178 138 103, 169 0·45 0·99
Salmon group 115 73, 166 130 82, 160 0·47
Control group 109 94, 153 120 93, 191 0·49
Pyridoxal 5 0-phosphate (vitamin B6) (nmol/l)
Cod group 42·4 27·2, 52·5 35·2 30·2, 49·1 0·65 0·015 0·92A
Salmon group 38·9 27·1, 52·5 46·5 31·3, 65·0 0·017 0·30B
Control group 38·5 32·1, 49·8 43·6 26·9, 52·7 0·90 0·13C
Pyridoxal (vitamin B6) (nmol/l)
Cod group 14·0 10·4, 16·3 13·9 10·2, 15·9 0·33 0·066
Salmon group 12·7 11·5, 18·4 16·1 13·2, 18·4 0·038
Control group 17·1 10·4, 22·2 15·6 11·9, 19·5 0·90
4-Pyridoxic acid (vitamin B6) (nmol/l)
Cod group 17·0 13·4, 23·1 19·9 13·5, 22·7 0·53 0·064
Salmon group 18·2 14·5, 22·8 22·1 17·3, 27·2 0·016
Control group 16·1 14·7, 21·9 17·8 15·3, 20·9 0·40
Folate (vitamin B9) (nmol/l)
Cod group 18·5 12·9, 23·2 16·4 13·4, 21·5 0·64 0·57
Salmon group 19·4 13·4, 25·6 17·3 12·5, 20·2 0·036
Control group 18·2 14·5, 22·2 17·5 14·7, 20·4 0·40
Cobalamin (vitamin B12) (pmol/l)
Cod group 336 262, 399 339 264, 393 0·82 0·094
Salmon group 293 249, 346 311 279, 390 0·010
Control group 282 272, 379 301 239, 365 0·84
25-Hydroxyvitamin D3 (nmol/l)
Cod group 64·2 49·7, 76·5 44·5 37·3, 56·7 4·0 × 10−5 0·0011 0·93A
Salmon group 70·6 54·6, 84·7 58·1 51·1, 68·1 8·0 × 10−5 0·0060B
Control group 62·0 52·4, 76·0 45·1 40·7, 56·7 8·0 × 10−4 0·013C
α-Tocopherol (vitamin E) (μmol/l)
Cod group 37·9 30·8, 47·2 36·0 31·4, 42·7 0·37 0·35
Salmon group 31·7 29·0, 36·2 32·0 27·9, 37·5 0·31
Control group 31·3 30·0, 40·4 35·2 27·8, 40·1 0·55
γ-Tocopherol (vitamin E) (μmol/l)
Cod group 2·81 1·79, 3·38 2·75 2·99, 3·24 0·91 0·60
Salmon group 2·06 1·83, 3·23 2·17 1·73, 2·98 0·22
Control group 2·43 2·13, 3·23 2·57 2·15, 2·83 0·41
Phylloquinone (vitamin K1) (nmol/l)
Cod group 0·79 0·40, 1·58 0·92 0·51, 1·59 0·80 0·69
Salmon group 0·54 0·30, 1·21 0·64 0·47, 1·04 0·37
Control group 0·69 0·50, 1·00 0·77 0·67, 0·93 0·083
* No differences were seen between the groups at baseline (Kruskal–Wallis test). Results are presented for twenty-two participants in the Cod group, twenty-two participants in the
Salmon group and nineteen participants in the Control group.
†Within-group changes were tested using Wilcoxon’s signed-rank test.
‡ Changes within the Cod group, Salmon group and Control group were compared using ANCOVA with adjustment for baseline values after log transformation.
§ Changeswithin theCod groupwere comparedwith theControl group (A), changeswithin the Salmon groupwere comparedwith theControl group (B), changeswithin theCod group
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but was not sufficient to prevent the expected seasonal
decrease in serum 25-hydroxyvitamin D3 concentration in
the autumn in Norway.
We have previously demonstrated that a high salmon intake
(750 g/week) improved post-prandial glucose regulation in
these study participants, whereas high cod intake (750 g/week)
did not affect glucose regulation after 8 weeks intervention(20).
The estimated intakes of energy and macronutrients (protein,
fat and carbohydrates) as well as estimated physical activity
were similar between the experimental groups at baseline and
did not change from baseline to endpoint(20). In the present
paper, we extended the statistical analyses of estimated intakes
and show that no differences were seen between the groups for
estimated intakes of vitamins A, B1, B2, B3, B6, B9, C, D and E
at baseline, and of these vitamins, only vitamin D estimated
intake increased from baseline to endpoint in the Salmon group
when compared with the Cod group and the Control group. The
presented findings regarding estimated intakes of energy, mac-
ronutrients(20) and vitamins based on food diaries give a good
indication that the participants did not change their dietary habits
during the study period, except for the inclusion of cod or
salmon in the fish-eating groups.
In humans, cutaneous synthesis of 25-hydroxyvitamin D3
stimulated by sunlight is the major source of vitamin D(19).
The participants in the present study were living in Bergen,
in South-Western Norway, at 60° north latitude. The baseline
visits were in the last week of August and the three first weeks
of September, with the endpoint visits starting in the middle of
October and lasting throughout the first third of November.
The study was thus conducted in a period when Bergen usu-
ally experiences a lot of overcast weather with little sun, and
the inhabitants have little chance of getting direct sunshine on
their skin for cutaneous synthesis of vitamin D3. The autumn
of 2011, when the present study was conducted, was no
exception with 4 d of fair weather and 64 rainy days with a
total of 783 mm rainfall during the 80 d of the study period(26).
A reduction in circulating vitamin D is expected in the autumn
this far north of the Equator since the intensity of UVB
radiation is too low for subcutaneous production of
vitamin D(27,28), unless the vitamin D intake from food or
supplements is increased. The Nordic Council of Ministers
recommends a daily intake of 10 μg vitamin D for the adult
Nordic population (<75 years) and recommends circulating
25-hydroxyvitamin D concentrations ≥50 nmol/l(29). At base-
line, fifty of the sixty-three participants (84 %) had serum
25-hydroxyvitamin D3 concentration >50 nmol/l, but 8 weeks
later, this was seen in 49 % of the participants (thirty-one
participants). Fatty fish such as salmon is regarded to be a good
dietary source of vitamin D3(1,21), andwe expected that the high
intake in the Salmon group of the present study would be
sufficient to sustain the serum 25-hydroxyvitamin D3 concen-
tration throughout autumn. However, although the median
daily vitamin D intake was estimated to be 11·9 μg (inter-
quartile range 10·0, 14·0 μg) in the Salmon group, which was
above the recommendation of 10 μg vitamin D per d, the serum
25-hydroxyvitamin D3 concentration decreased in this group,
albeit to a lesser degree when compared with both the Cod
group and the Control group. Thus, a weekly intake of 750 g
salmon was insufficient to prevent the seasonal reduction in
serum 25-hydroxyvitamin D3 in the autumn in this group of
healthy adults with overweight or obesity living in South-
Western Norway.
The contents of vitamin A, vitamin B1, niacin and vitamin B6
are higher per wet weight in salmon fillet compared with cod
fillet, whereas amounts of vitamin E, vitamin B2, folate and
vitamin C are comparable in cod and salmon fillets(21). We
found no differences in the estimated dietary intakes of these
eight vitamins when comparing the food diaries from the Cod
group, the Salmon group and the Control group. The partici-
pants had a varied diet throughout the study period and
regularly reported that they consumed common foodstuffs that
are good sources of different vitamins, such as dairy products
(vitamins A and B2, folate), eggs (vitamins A, B1, B2, E and
folate), fruits (vitamin C, folate), vegetables (vitamins A and
C, folate), meat (vitamins A, B1, B2 and B6, niacin, folate), grains
(vitamins B1, B2 and B6, folate, niacin), nuts (vitamins B1, B2, B6
and E, niacin, folate), legumes (vitamins A, B1, B2 and C, folate)
and berries (vitamins C and E, folate)(21). In line with this, no
changes in serum concentrations of vitamins A, B1, B2, B6, E,
and niacin and folate were found within or between any of
the experimental groups.
Vitamin K1 and cobalamin are not included in the food
database (Mat på data) used for estimations of dietary intakes
in the present study; therefore, we were not able to report
estimated intake of these vitamins. Little information is available
on the content of vitamin K1 in various foods, but this vitamin is
found in highest amounts in plants and vegetable oils(30), and no
changes were seen in serum vitamin K1 concentration in any of
the groups during the intervention. Only a few food types are
rich in vitamin B12, such as fish, meat, egg and dairy products(30)
which were regularly consumed by our participants, in addition
to liver and kidney(30) which were not reported in the food dia-
ries by any of the participants in the present study. The bioavail-
ability of vitamin B12 is also an issue when considering food
sources of this vitamin, and it has been reported that for humans,
the bioavailability is several times higher from milk, fish and







Change in serum 25-OH vitamin D3 concentrations (nmol/l)
Fig. 2. Change in serum concentrations of 25-hydroxyvitamin D3 from baseline
to 8 weeks. Results are presented for twenty-two participants in the Cod group,
twenty-two participants in the Salmon group and nineteen participants in the
Control group and are presented as medians and 25th, 75th percentiles.
Changes within the Cod group, Salmon group and Control group were com-
pared using ANCOVA with adjustment for baseline values after log transforma-
tion followed by Tukey’s honestly significant difference test. a,b Bars with
different letters are significantly different (P< 0·05).
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meat compared with eggs(31). The cobalamin content in farmed
Atlantic salmon is approximately three times that in cod(1),
but still no differences were observed between the groups for
changes in serum cobalamin concentrations after 8 weeks
intervention.
The present study has some strengths and limitations.
Strengths include the measurement of both water-soluble and
fat-soluble vitamins and the use of 5-d dietary registrations at
baseline and endpoint for estimation of vitamin intake. A pos-
sible limitation of the present study is that the results obtained
may not be valid for individuals with different demographics
such as BMI, living at different latitudes and different lifestyles
than those in the present work; thus, additional studies are
needed to address these factors. Also, the effects of a longer
intervention period on the serum micronutrient concentrations
should be investigated. The vitamin D serum concentration for
the participants that habitually consumed >1 fish dinner per
week may have been lower in the beginning of study than nor-
mal since these participants had a 4 week fish-free period before
the baseline visit. The cod and salmon fillets used in the present
study were randomly chosen from different batches in Lerøy’s
warehouse in Bergen and were representative for cod and
salmon sold in Norwegian grocery stores. We did not conduct
our own analyses of vitamin contents in these batches, but
insteadwe used average values from the official Norwegian food
database.
Conclusion
A high intake of salmon curbed but was not sufficient to prevent
a decrease in serum 25-hydroxyvitamin D3 concentration in
autumn in South-Western Norway in adults with overweight/
obesity. We also found that high intake of cod or salmon did
not affect serum concentrations of the other investigated vitamins.
The Norwegian Directorate of Health recommends a weekly
intake of 300–450 g fish, of which at least 200 g should be fatty fish,
for the general public(32); however, findings in the present study
suggest that such intake will not be sufficient to prevent the
decline in serum vitamin D concentration in autumn at 60° north
latitude. This result suggests that it is difficult to sustain non-
deficient levels of vitamin 25-hydroxyvitamin D3 in autumn in
South-Western Norway through dietary intake alone.
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